Buy Divi's Lab, target Rs 767, stop loss Rs 718: Kunal Saraogi

In a chat with ET Now, Kunal Saraogi, technical analyst, www.equityrush.com, talks about the outlook of Divi's Laboratories.

In the pharmaceutical space, you are bullish on Divi's Laboratories. What is your target and stop loss?

We are bullish both on Biocon and Divi's Lab. Divi's Lab has broken out from a major resistance level. We got a buy target on Divi's Lab with a stop loss of about Rs 718 and a target of Rs 767. The stock has broken out very decisively and the stock should made its target soon enough.